Literature DB >> 17303710

Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease.

Patrick H McNulty1, Bryan J Robertson, Mark A Tulli, Joshua Hess, Lisa A Harach, Sofia Scott, Lawrence I Sinoway.   

Abstract

Pathological formation of reactive oxygen species within the coronary circulation has been hypothesized to mediate some clinical manifestations of ischemic heart disease (IHD) by interfering with physiological regulation of coronary tone. To determine the degree to which coronary tone responds to acute changes in ambient levels of oxidants and antioxidants in vivo in a clinical setting, we measured the effect of an acute oxidative stress (breathing 100% oxygen) on coronary capacitance artery diameter (quantitative angiography) and blood flow velocity through the coronary microcirculation (intracoronary Doppler ultrasonography) before and after treatment with the antioxidant vitamin C (3-g intravenous infusion) in 12 IHD patients undergoing a clinical coronary interventional procedure. Relative to room air breathing, 100% oxygen breathing promptly reduced coronary blood flow velocity by 20% and increased coronary resistance by 23%, without significantly changing the diameter of capacitance arteries. Vitamin C administration promptly restored coronary flow velocity and resistance to a slightly suprabasal level, and it prevented the reinduction of coronary constriction with rechallenge with 100% oxygen. This suggests that acute oxidative stress produces prompt and substantial changes in coronary resistance and blood flow in a clinical setting in patients with IHD, and it suggests that these changes are mediated by vitamin C-quenchable substances acting on the coronary microcirculation. This observation may have relevance for clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303710     DOI: 10.1152/japplphysiol.00595.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  36 in total

Review 1.  Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  Stephen P Juraschek; Eliseo Guallar; Lawrence J Appel; Edgar R Miller
Journal:  Am J Clin Nutr       Date:  2012-04-04       Impact factor: 7.045

Review 2.  Regulation of exercise blood flow: Role of free radicals.

Authors:  Joel D Trinity; Ryan M Broxterman; Russell S Richardson
Journal:  Free Radic Biol Med       Date:  2016-02-10       Impact factor: 7.376

3.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

Review 4.  Hyperoxia in anaesthesia and intensive care.

Authors:  E Horncastle; A B Lumb
Journal:  BJA Educ       Date:  2019-04-17

5.  [Author reply].

Authors:  B Peckel; M W Hollmann
Journal:  Anaesthesist       Date:  2013-02       Impact factor: 1.041

Review 6.  Recent major advances in cardiovascular pharmacotherapy.

Authors:  James Milner; Andreia Cunha; Carlota Gamboa-Cruz; Julie Reis; Márcia Campos; Natália António
Journal:  Eur J Clin Pharmacol       Date:  2018-03-27       Impact factor: 2.953

7.  Effect of vitamin C on hyperoxia-induced vasoconstriction in exercising skeletal muscle.

Authors:  Sushant M Ranadive; Michael J Joyner; Branton G Walker; Jennifer L Taylor; Darren P Casey
Journal:  J Appl Physiol (1985)       Date:  2014-09-18

Review 8.  Hyperoxia: a review of the risks and benefits in adult cardiac surgery.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2012-12

9.  Vasoconstrictor responsiveness during hyperbaric hyperoxia in contracting human muscle.

Authors:  Darren P Casey; Michael J Joyner; Paul L Claus; Timothy B Curry
Journal:  J Appl Physiol (1985)       Date:  2012-11-15

10.  The impact of inspired oxygen concentration on tissue oxygenation during progressive haemorrhage.

Authors:  Alex Dyson; Ray Stidwill; Val Taylor; Mervyn Singer
Journal:  Intensive Care Med       Date:  2009-07-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.